Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
Georg Semmler(University of Southern Denmark), David Bauer(Austrian Academy of Sciences), Lukas Hartl(Medical University of Vienna), Katharina Stopfer(Medical University of Vienna), Bernhard Scheiner(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Theresa Bucsics(Medical University of Vienna), Benedikt Hofer(Medical University of Vienna), Daniela Neumayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), L. Fritz(Medical University of Vienna), Zhenwei Yang(First Affiliated Hospital of Liaoning Medical University), Anna Schedlbauer(Medical University of Vienna), Jurij Maurer(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), F Köck(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences)
Cited by 94
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239